The estimated Net Worth of Kenneth R Weisshaar is at least $123 ezer dollars as of 17 May 2013. Kenneth Weisshaar owns over 1,000 units of Orthofix Medical Inc stock worth over $123,070 and over the last 20 years Kenneth sold OFIX stock worth over $0.
Kenneth has made over 1 trades of the Orthofix Medical Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Kenneth bought 1,000 units of OFIX stock worth $26,400 on 17 May 2013.
The largest trade Kenneth's ever made was buying 1,000 units of Orthofix Medical Inc stock on 17 May 2013 worth over $26,400. On average, Kenneth trades about 59 units every 0 days since 2005. As of 17 May 2013 Kenneth still owns at least 7,073 units of Orthofix Medical Inc stock.
You can see the complete history of Kenneth Weisshaar stock trades at the bottom of the page.
Kenneth's mailing address filed with the SEC is 875 PARK AVE APT 2D, , NEW YORK, NY, 10021.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth és Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: